Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
 
  
   
Insider Information:   Hooper Anthony C
Relationship:   Director
City:   Princeton
State:   NJ
   
Insider Summary:
  
   
Companies Owned :   4    
Direct Shares   618,962    

Indirect Shares

   5,248      
Direct Value   $77,507,419    

Indirect Value

   $211,232      
Total Shares   624,210      
Total Value   $77,718,651      


Bristol-Myers Squibb Co $8,177,593 Amgen Inc $64,759,247 MannKind Corp $792,689 Beigene Ltd $3,777,891 Bristol-Myers Squibb Co $8,177,593 Amgen Inc $64,759,247 MannKind Corp $792,689 Beigene Ltd $3,777,891
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :
    1   
    0    

     Stock price went up :
    1   
    0    
     Stock price went down :
    0   
    0    
   
     Gain/Loss Ratio :
   1.0   
   0.0   
     Percentage Gain/Loss :
   58.4%
   0.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Bristol-Myers Squibb Co BMY SVP ComOps Pres USJap ... 2011-05-13 203,170 2011-05-13 5,248    Premium*  
            Amgen Inc AMGN EVP, Global Commercial... 2018-05-03 215,147 2011-10-27 0    Premium*  
            MannKind Corp MNKD Director 2024-02-04 176,153 0    Premium*  
            Beigene Ltd BGNE Director 2022-06-22 24,492 2021-06-16 0    Premium*  
* Premium Members only  

Records found :    93         Free Registration Required For Full Results.    Limit: 25

 Download
  Page 2 of 4
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

  
3m +/-  
Form
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2014-01-31 4 A $0.00 $0 D/D 5,044 98,402 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2008-09-10 4 D $21.67 $83,906 D/D (3,872) 98,459 0 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2009-09-21 4 D $22.52 $87,175 D/D (3,871) 99,837 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2008-03-02 4 D $22.61 $26,635 D/D (1,178) 102,331 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2008-03-01 4 D $22.61 $23,469 D/D (1,038) 103,509 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2007-09-10 4/A D $0.00 $0 D/D (3,882) 104,547 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2007-09-10 4 D $0.00 $0 D/D (3,871) 104,558 0 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2009-02-19 4/A D $20.51 $246,099 D/D (11,999) 108,419 0 -
BMY Bristol-Myers Squibb Co SVPComOps PresUSJapInterc   •       –      –    2010-09-20 4 D $27.81 $107,430 D/D (3,863) 108,519 0 -
BMY Bristol-Myers Squibb Co President US PharmaceuticalsOf   •       –      –    2007-05-24 3/A IO $0.00 $0 D/D 0 110,088 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2010-03-02 4 D $0.00 $0 D/D (17,259) 110,627 0 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2010-03-07 4 D $24.60 $71,857 D/D (2,921) 112,382 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2006-06-20 4 D $25.48 $61,942 D/D (2,431) 113,165 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2015-01-28 4 D $158.89 $152,376 D/D (959) 113,952 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2014-04-27 4 D $111.41 $172,240 D/D (1,546) 114,664 0 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2010-03-06 4 D $24.60 $99,409 D/D (4,041) 115,303 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2015-03-02 4 D $157.72 $507,070 D/D (3,215) 115,334 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2006-03-07 4 D $22.73 $42,323 D/D (1,862) 115,596 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2009-03-06 4 D $18.35 $42,150 D/D (2,297) 115,707 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2014-03-12 4 D $124.27 $3,422,396 D/D (27,540) 116,210 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2006-03-07 4 A $22.73 $545,679 D/D 24,007 117,458 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2009-03-02 4 D $17.74 $22,760 D/D (1,283) 118,004 0 -
AMGN Amgen Inc EVP, Global Commercial Ops.   •       •      –    2015-01-30 4 A $0.00 $0 D/D 4,597 118,549 0 -
BMY Bristol-Myers Squibb Co President US Pharmaceuticals   •       –      –    2009-03-01 4 D $18.41 $20,822 D/D (1,131) 119,287 0 -
BMY Bristol-Myers Squibb Co President Americas   •       –      –    2010-03-06 4 OE $24.60 $214,438 D/D 8,717 119,344 0 -
  93  Records found
  1   2  3   4      
  Page 2 of 4  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us